At the CCOI-Stanford Summit, Goldberg calls for collaborative trial models that could redefine efficiency and standardization ...

As clinical trial complexities grow, ICH E6 (R3) updates emphasize smarter monitoring, greater participant focus, and a stronger tech role.

Tulsi Therapeutics achieves groundbreaking success in animal trial for liver disease treatment, paving way for human trials.

The Vision Center at Children’s Hospital Los Angeles is developing a protocol for a phase 1 clinical trial for the first gene ...

Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...

For those seeking cataract surgery in Bozeman, Vance Thompson Vision offers a high level of surgical expertise supported by ...

Tulsi Therapeutics achieves groundbreaking success with novel stem cell–exosome therapy for chronic liver failure at ...

For individuals considering LASIK in Cedar Rapids, Vance Thompson Vision offers world-class care, cutting-edge technology, ...

Durham-based TruTechnologies has secured a strategic growth investment from LLR Partners to accelerate the expansion of its real-time clinical trial oversight solutions and fuel the next phase of ...

For those considering LASIK in Northern Colorado, Vance Thompson Vision offers nationally recognized care delivered by an ...

Viatris reported that its MR-139 ophthalmic ointment failed to meet its primary endpoint in a Phase III blepharitis trial, while advancing its MR-141 and MR-142 candidates in presbyopia and night ...